Fezakinumab is a potent monoclonal antibody to interleukin-22 (IL-22). Fezakinumab can be used to study immune system diseases and inflammation-related conditions such as psoriasis, rheumatoid arthritis and atopic dermatitis.
CAS Number:
[1007106-86-6]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted